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The following annotated bibliography provides information in a num-
ber of areas. The state laws related to legalizing medical marijuana in ef-
fect as of January 2015 are summarized. In addition to the statute summar-
ies, annotations of select articles are provided. The greatest portion of ma-
terials annotated involves federalism discussions and employment related 
issues. Also included, but to a much lesser extent are family law, transpor-
tation, and attorney ethics. Additionally, a few articles on state regulatory 
power and other topics are included. As this bibliography was being creat-
ed, the U.S. House of Representatives and Senate introduced legislation to 
reclassify marijuana within the Controlled Substances Act. Those bills are 
referenced in a section of the bibliography. At the end of the document 
there are lists of recent newspaper coverage of the medical marijuana laws 
and debates in the United States. The creators of this bibliography did not 
attempt to cover the breadth of information available on this topic. These 
resources are meant to provide a broad picture of the medical marijuana 
discussion at this time, along with some history of the topic. There is signif-
icantly more literature available on medical marijuana and the various 
legal issues surrounding it. However, this bibliography will give research-
ers a good start on compiling relevant materials for further study. 
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STATUTES 
In this section a summary of all states currently with medical marijua-
na laws is provided. Illinois is listed first as the focus of the symposium is 
the newly enacted medical marijuana law in Illinois. 
 
ILLINOIS 
The Compassionate Use of Medical Cannabis Pilot Program Act, 410 ILL. 
COMP. STAT. ANN. 130/1-130/199 (West, Westlaw through P.A. 98-
1125 of the 2014 Reg. Sess.). 
Under the statute, a four-year pilot program has been established 
where a registered qualifying patient may possess and use medical marijua-
na. A qualifying patient is a person who has been diagnosed by a physician 
as having a debilitating medical condition, and has obtained a written certi-
fication from his/her physician, and has followed all the procedures to be-
come registered with the Department of Public Health.  
Possession: 2½ ounces 
Homegrown: Prohibited 
Dispensaries: Yes 
Illnesses: Cancer, glaucoma, HIV/AIDS, hepatitis C, amyotrophic lat-
eral sclerosis, Crohn’s disease, Alzheimer’s disease, cachexia, muscular 
dystrophy, severe fibromyalgia, spinal cord disease, including but not lim-
ited to arachnoiditis, Tarlov cysts, hydromyelia, syringomyelia, rheumatoid 
arthritis, fibrous dysplasia, spinal cord injury, traumatic brain injury and 
post-concussion syndrome, multiple sclerosis, Arnold-Chiari malformation, 
spinocerebellar ataxia (SCA), Parkinson’s, Tourette’s, myoclonus, dystonia, 
reflex sympathetic dystrophy, RSD (complex regional pain syndromes type 
I), causalgia, CRPS (complex regional pain syndromes type II), neurofi-
bromatosis, chronic inflammatory demyelinating polyneuropathy, Sjogren’s 
syndrome, lupus, interstitial cystitis, myasthenia gravis, hydrocephalus, 
nail-patella syndrome, residual limb pain, or the treatment of these condi-
tions or any other debilitating medical condition or its treatment that is add-
ed by the Department of Public Health. 
Caregivers: Must be at least twenty-one years of age, agree to assist 
with a patient’s medical use of marijuana, not convicted of an excluded 
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ALASKA 
Medical Uses of Marijuana for Persons Suffering from Debilitating Medical 
Conditions Act, ALASKA STAT. §§ 17.37.010-17.37.080 (West, 
Westlaw through Ch. 116 (End) of the 2014 2d Reg. Sess.).  
Under the statute, patients who possess a Registry Identification Card 
for Medical Use of Marijuana may use, possess, and cultivate marijuana for 
personal use. The Registry is maintained by the Department of Health and 
Social Services. To be eligible for a card, patients must be placed on the 
Registry. This requires a signed statement from the patient’s physician stat-
ing that the patient has been diagnosed with a debilitating medical condition 
and that “the physician has concluded that the patient might benefit from 
the medical use of marijuana.” 
Possession: One ounce of usable marijuana. 
Homegrown: Six marijuana plants, with no more than three mature 
and flowering plants producing usable marijuana at any one time. 
Dispensaries: No 
Illnesses: Cancer, glaucoma, HIV/AIDS, cachexia, severe pain, severe 
nausea, seizures, epilepsy, multiple sclerosis, or any other condition ap-
proved by the Department. 
Caregivers: Must be at least twenty-one years old, have no felony 
convictions for offenses related to controlled substances, and he/she must 






Arizona Medical Marijuana Act, ARIZ. REV. STAT. ANN. §§ 36-2801  
to -2819 (West, Westlaw through the Second Regular and Second Special 
Sessions of the Fifty-First Legislature). 
Under the statute, a qualifying patient and a designated caretaker may 
possess or cultivate the requisite amount of marijuana so long as they have 
properly joined the Arizona Department of Health Services registry. To be 
considered a qualifying patient, a person must obtain a written diagnosis for 
a debilitating medical condition from his/her physician. In addition, the law 
also recognizes “visiting qualifying patient[s].” These are people with valid 
medical recommendations from other medical marijuana states. However, 
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the statute does not permit the cultivation of marijuana within twenty-five 
miles of a state-licensed dispensary.  
Possession: 2 ½ ounces of usable marijuana. 
Homegrown: Twelve marijuana plants contained in an enclosed, 
locked facility. 
Dispensaries: No 
Illnesses: Cancer, glaucoma, HIV/AIDS, hepatitis C, amyotrophic lat-
eral sclerosis, Crohn’s Disease, Alzheimer’s Disease, chronic or debilitating 
disease or medical condition or its treatment that produces one or more of 
the following: cachexia or wasting syndrome, severe and chronic pain, se-
vere nausea, seizures, severe and persistent muscle spasms, including those 
characteristic of multiple sclerosis, and any other medical condition or its 
treatment added by the Department. 
Caregivers: Must be at least twenty-one years old, have agreed to as-
sist with patient’s use, have no excluded felony offense convictions, and 
assists five or less qualifying patients. 
Agency Website: http://azdhs.gov/preparedness/medical-marijuana/  
 
CALIFORNIA 
Medical Marijuana Program, CAL. HEALTH & SAFETY CODE §§ 11362.7-
1136.9 (West, Westlaw through Current with urgency legislation 
through Ch. 931 of 2014 Reg. Sess.). 
Under the statute, eligible patients may possess and cultivate marijua-
na. Eligible patients are seriously ill Californians whose physicians have 
deemed marijuana to be an appropriate treatment. To be eligible, patients 
must present their physicians’ written or oral recommendation. In addition, 
California’s Department of Public Health administers a registry, but it is 
voluntary. 
Possession: Eight ounces (or more if doctor recommended). 
Homegrown: Six mature plants or twelve immature plants. 
Dispensaries: Yes 
Illnesses: AIDS, anorexia, arthritis, cachexia, cancer, chronic pain, 
glaucoma, migraine, persistent muscle spasms, including, but not limited to, 
spasms associated with multiple sclerosis, seizures (including seizures as-
sociated with epilepsy), severe nausea, and any other chronic or persistent 
medical symptom that either substantially limits the ability of the person to 
conduct one or more major life activity as defined in the Americans with 
Disabilities Act of 1990, or if not stopped may cause serious harm to the 
patient’s safety or physical or mental health. 
Caregivers: At least eighteen-years old (unless the primary caregiver 
is the parent of a minor who is a qualified patient or a person with an identi-
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fication card, or is a person otherwise entitled to make medical decisions 
under state law), designated by a qualified patient or by a person with an 
identification card, who has consistently assumed responsibility for the 





Medical use of marijuana by persons diagnosed with debilitating medical 
conditions—unlawful acts—penalty—medical marijuana program 
cash fund, COLO. REV. STAT. ANN. § 18 to 18-406.3 (West, Westlaw 
through the Second Reg. Sess. of the Sixty-Ninth Gen. Assemb.).  
COLO. CONST. art. XVIII, § 14. 
Under Article XVIII and the statute, any patient or primary caregiver 
in lawful possession of a registry identification card may engage in or assist 
in the medical use of marijuana. To obtain a registry identification card a 
patient must reside in Colorado and complete the application process. Pa-
tients who do not join the registry and are arrested for possession or cultiva-
tion of marijuana may argue an “affirmative defense . . . [of] medical neces-
sity.” 
Possession: Two ounces of usable marijuana. 
Homegrown: Six plants. 
Dispensaries: Yes 
Illnesses: Cancer, glaucoma, HIV/AIDS, cachexia, persistent muscle 
spasms, seizures, severe nausea, and severe pain. 
Caregivers:  Must be at least eighteen-years old, must not be the pa-
tient or the patient’s physician, must have significant responsibility for 
managing the well-being of a patient who has a debilitating medical condi-
tion, and must not have a primary caregiver of his/her own. May register 
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CONNECTICUT 
Palliative Use of Marijuana, CONN. GEN. STAT. ANN. §§21a-408 to 21a-
408q (West, Westlaw through the 2014 Feb. Reg. Sess.). 
Under the statute, a patient must obtain written certification from 
his/her physician and register with the Department of Consumer Protection. 
To be a qualifying patient, he/she must be at least eighteen-years old, a res-
ident of Connecticut, and be diagnosed by a physician as having a debilitat-
ing medical condition. This does not include inmates at correctional institu-
tions. 
Possession: The combined amount of marijuana possessed by the 
qualifying patient and the caregiver may not exceed an amount of usable 
marijuana reasonably necessary to ensure uninterrupted availability for one 




Illnesses: Cancer, glaucoma, AIDS/HIV, Parkinson’s disease, multi-
ple sclerosis, damage to the nervous tissue of the spinal cord with objective 
neurological indication of intractable, spasticity, epilepsy, cachexia, wast-
ing syndrome, Crohn’s disease, post-traumatic stress disorder, any medical 
condition, medical treatment or disease approved by the Department of 
Consumer Protection. 
Caregivers: Must be eighteen years old and have agreed to undertake 
responsibility for managing the well-being of the qualifying patient with 






The Delaware Medical Marijuana Act, DEL. CODE ANN. tit. 16, §§ 4901a-
4926a (West, Westlaw through 79 laws 2014). 
Under the statute, medical use of marijuana is permitted with a doc-
tor’s recommendation. Qualifying patients must be eighteen years old and 
they must send their doctor’s written documentation to the state Department 
of Health and Social Services. The department will then issue a mandatory 
I.D. card. The statute also recognizes qualifying patients from other states. 
Qualifying patients who do not have an I.D. card may raise an affirmative 
defense motion to dismiss marijuana possession charges.  
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Possession: Six ounces of usable marijuana. 
Homegrown: Home cultivation is prohibited; only licensed compas-
sion centers may cultivate marijuana. 
Dispensaries: Yes 
Illnesses: cancer, multiple sclerosis, HIV/AIDS, hepatitis C, ALS, 
Alzheimer’s disease, post-traumatic stress disorder, conditions that cause 
severe, debilitating pain, wasting syndrome, intractable nausea, and sei-
zures. 
Caregivers: Must be at least twenty-one years old and have no felony 
convictions for violent crimes or drug crimes (state and federal). S/he is 




DISTRICT OF COLUMBIA 
Use of Marijuana for Medical Treatment, D.C. CODE §§ 7-1671.01 to7-
1671.13 (West, Westlaw through Nov. 25, 2014). 
Under the statute, a qualifying patient or qualifying caretaker may pos-
sess and administer medical marijuana. They may also possess and use par-
aphernalia, only for treatment of a qualifying medical condition or the side 
effects of a qualifying medical treatment if they have obtained a written and 
signed recommendation from his/her physician and registered with the 
mayor. 
Possession: Two ounces 
Homegrown: Home cultivation is prohibited. 
Dispensaries: Yes 
Illnesses: Cancer, HIV/AIDS, glaucoma, multiple sclerosis and other 
muscle spasticity disorders, and any other condition that is “(i) [c]hronic or 
long-lasting; (ii) [d]ebilitating; (iii) [a] serious medical condition for which 
the use of medical marijuana is beneficial.”  
Caregivers: Must be at least eighteen years old, registered with the 





Medical Use of Marijuana, HAW. REV. STAT. §§ 329-121 to329-128 
(West, Westlaw through 2014 Reg. Sess.). 
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Under the statute, a qualifying patient is permitted the medical use of 
marijuana if he/she has been diagnosed with a debilitating medical condi-
tion by a physician, and the physician has certified in writing that, in the 
physician's professional opinion, the potential benefits of the medical use of 
marijuana would likely outweigh the health risks for the particular qualify-
ing patient. Qualifying patients and caregivers must be registered with the 
Department of Health. 
Possession: Four ounces 
Homegrown: Seven plants (mature or immature). 
Dispensaries: Yes 
Illnesses: Cachexia, cancer, chronic pain, Crohn’s disease, epilepsy 
and other conditions characterized by seizures, glaucoma, HIV/AIDS, mul-
tiple sclerosis and other muscle spasticity disorders, nausea (other condi-
tions subject to state approval). 
Caregivers: “Primary caregiver” means a person who is at least eight-
een years old, other than the qualifying patient and the qualifying patient’s 
physician, who has agreed to undertake responsibility for managing the 
well-being of the qualifying patient with respect to the medical use of mari-
juana. In the case of a minor or an adult lacking legal capacity, the primary 





Maine Medical Use of Marijuana Act, ME. REV. STAT. ANN. tit. 13, §§ 13-
3301 to13-3316 (West, Westlaw through 2014 Reg. Sess.). 
Under the statute, qualifying patients may grow and cultivate medical 
marijuana. To be a qualifying patient one must have been diagnosed with a 
debilitating medical condition and have a valid written certification pertain-
ing to the use of medical marijuana. A valid written certification is a docu-
ment signed by a medical provider stating the patient is likely to gain a 
therapeutic benefit from using medical marijuana.  
Possession: 2 ½ ounces 
Homegrown: Six marijuana plants (up to three may be mature). 
Dispensaries: Yes 
Illnesses: Epilepsy and other conditions characterized by seizures, 
glaucoma, multiple sclerosis and other muscle spasticity disorders, nausea, 
HIV/AIDS, cancer, hepatitis C, Lou Gehrig’s disease, Crohn’s disease, 
Alzheimer’s disease, nail-patella syndrome, cachexia, and other conditions 
subject to state approval.  
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Caregivers: Must be at least twenty-one years old and have never 
been convicted of a drug offense. 
Agency Website: http://www.maine.gov/dhhs/dlrs/mmm/index.shtml 
 
MARYLAND 
Natalie M. Laprade Medical Marijuana Commission, MD. CODE ANN., 
HEALTH §§ 13-3301 to 13-3316 (West, Westlaw through 2014 Reg. 
Sess.). 
Under the statute a qualifying patient, may possess medical marijuana. 
To be a qualifying patient one must obtain written certification from a treat-
ing physician that the potential benefits of the medical use of marijuana 
would likely outweigh the health risks for the patient. 
Possession: An amount constituting a thirty-day supply. The Commis-
sion will determine the amount. 
Homegrown: No 
Dispensaries: Yes 
Illnesses: Chronic or debilitating disease or medical condition that re-
sults in a patient being admitted into hospice or receiving palliative care, a 
chronic or debilitating disease or medical condition or the treatment of a 
chronic or debilitating disease or medical condition that produces: cachexia, 
anorexia, wasting syndrome, severe pain, severe nausea, seizures, severe or 
persistent muscle spasms, and severe conditions or The Commission may 
approve applications that include any other condition that is severe and for 
which other medical treatments have been ineffective if the symptoms rea-
sonably can be expected to be relieved by the medical use of marijuana. 
Caregivers: A person who has agreed to assist with a qualifying pa-
tient’s medical use of marijuana. If the qualifying patient is under eighteen 






Humanitarian Medical Use of Marijuana, MASS. GEN. LAWS ch. 94C, §§ 1-
1 to 1-14 (West, Westlaw through chs. 1 to 505 of the 2014 2d Ann. 
Sess.). 
Protection is provided for health care professionals, qualifying pa-
tients, personal care givers, and dispensary agents, for the medical use of 
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marijuana, who comply with the specification stated in the law. The law 
shall be administered by the Department of Public Health of the Common-
wealth of Massachusetts. Registration cards are issued to qualifying patients 
and caregivers via the Department. A qualifying patient is “a person who 
has been diagnosed by a licensed physician as having a debilitating medical 
condition.” MASS. GEN. LAWS ch. 94C, § 1-2(K). 
Possession: Sixty-day supply is equal to ten ounces. A certifying phy-
sician may alter this amount by presenting documentation supporting the 
additional need. 105 MASS. CODE REGS. § 725.004 (2013). 
Home Grown: Permitted upon obtaining a hardship cultivation regis-
tration. Cultivation is limited to the location specified in the application, 
registration is valid for one year, and the number of plants is limited to that 
sufficient to maintain a sixty-day supply solely for the patient’s use. 105 
MASS. CODE REGS. § 725.035 (2013). 
Dispensaries: Yes 
Illnesses: When debilitating the following conditions are included: 
cancer, glaucoma, HIV positive, AIDS, hepatitis C, ALS, Crohn’s disease, 
Parkinson’s disease, and MS. Also covered are “other debilitating condi-
tions as determined in writing by a qualifying patient’s certifying physi-
cian.” 105 MASS. CODE REGS. § 725.004 (2013). 
Caregivers: Must be twenty-one years of age or older. A qualifying 
patient may designate up to two caregivers. Generally, a caregiver may only 
provide care to one individual. Caregivers must attest s/he will not divert 
marijuana elsewhere and acknowledge that the rights of the caregiver are 
only applicable within the state of Massachusetts. MASS. GEN. LAWS ch. 






Michigan Medical Marihuana Act, MICH. COMP. LAWS ANN. §§ 
333.26421–333.26430 (West, Westlaw through P.A. 2014, No. 572 of 
the 2014 Reg. Sess. of the Ninety-Seventh Leg.). 
Qualifying patients, caregivers, and physicians are protected from ar-
rest, prosecution, penalty, or denial of rights or actions by professional dis-
ciplinary boards for the medical use of marihuana in accordance with this 
Act. The Act is administered by the Department of Licensing and Regulato-
ry Affairs. Registry identification cards are issued to qualifying patients and 
registered caregivers by the department. MICH. COMP. LAWS ANN. § 
333.26423. 
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Possession: 2 ½ ounces of useable marihuana. If held by a caregiver 
then 2 ½ ounces per qualifying patient to whom s/he is connected by proper 
registration. MICH. COMP. LAWS ANN. § 333.26424(a), (b)(1). 
Home Grown: Twelve plants. They must be kept in an “enclosed, 
locked facility.” MICH. COMP. LAWS ANN. § 333.26424(a), (b)(2). 
Dispensaries: No 
Illnesses: One or more of the following: cancer, glaucoma, HIV posi-
tive, AIDS, hepatitis C, ALS, Crohn’s disease, agitation of Alzheimer’s 
disease, nail-patella. A chronic debilitating disease or condition that results 
in: cachexia (wasting syndrome), severe and chronic pain, severe nausea, 
seizures, severe and chronic muscle spasms. And other medical conditions 
as approved by the department. MICH. COMP. LAWS ANN. § 333.26423(b). 
Caregivers: Caregivers must be twenty-one years of age or older, 
have no felony convictions within the past ten years, have never been con-
victed of a felony involving illegal drugs or an assaultive crime as defined 
in the code of criminal procedure, and must have agreed to assist with the 
patient’s use of medical marihuana. MICH. COMP. LAWS ANN. § 





Therapeutic Research Act; Medical Cannabis, MINN. STAT. ANN. §§ 
152.21–152.37 (West, Westlaw through the 2015 Reg. Sess. through 
ch. 2). 
The provision of medical cannabis to qualifying patients begins July 1, 
2015. The process is under the control of the Commissioner of Health. 
Qualifying patients apply to the commissioner to be enrolled in the registry 
program and in doing so agree to continue treatment for the qualifying con-
dition, report any changes in the condition, and to obtain medical cannabis 
only from a registered manufacturer. The law expressly prohibits the smok-
ing of marijuana. MINN. STAT. ANN. §§ 152.22, 152.25, 152.30. 
Possession: Thirty-day supply. 39 MINN. REG. 818 (Dec. 15, 2014). 
Home Grown: No 
Dispensaries: Yes. MINN. STAT. ANN. § 152.29. 
Illnesses: Cancer or a terminal illness with a less than one-year life 
expectancy, if the condition or treatment results in one or more of the fol-
lowing: severe or chronic pain, nausea or severe vomiting or severe wast-
ing, glaucoma, HIV or AIDS, Tourette’s syndrome, ALS, seizures, severe 
and persistent muscle spasms, Crohn’s disease, and any other medical con-
dition approved by the commissioner. MINN. STAT. ANN. § 152.22. 
472 NORTHERN ILLINOIS UNIVERSITY LAW REVIEW [Vol. 35 
Caregivers: Must be at least twenty-one years of age and not have any 
convictions for disqualifying felonies. Registered, designated caregivers are 
approved by the commission to assist  patients who have been identified by 
health care professionals to be unable to self-administer or acquire canna-
bis. MINN. STAT. ANN. § 152.22. 
Agency Website: http://www.health.state.mn.us/topics/cannabis/  
 
MONTANA  
Montana Marijuana Act, MONT. CODE ANN. §§ 50-46-301 to -344 (West, 
Westlaw through the 2013 Sess., and the 2014 Gen. Election). 
Provides legal protections for persons covered by the Act who use ma-
rijuana to alleviate symptoms associated with a debilitating condition. Also 
provides protection for those who cultivate, manufacture, deliver, and pos-
sess marijuana within the parameters of the Act as well as individuals who 
assist in some of these activities. The Act establishes reporting require-
ments and permits local governments to establish standards for the protec-
tion of those within their jurisdiction. The Act is administered by the De-
partment of Health and Human Services, which issues registration cards to 
patients, providers and marijuana infused product providers (MIPPs). The 
Department also provides for a “Landlord Permission Form,” which permits 
cultivation on rented property when properly obtained and approved. 
MONT. CODE ANN. §§ 50-46-301 to 50-46-302; MONT. ADMIN. R. 
37.107.110 (2011). 
Possession: Registered cardholders may possess twelve seedlings, a 
seedling being a plant less than twelve-inches tall, four  mature plants and 
one ounce of useable marijuana. 
http://dphhs.mt.gov/qad/Licensure/MMP/mmpfaq#159672069-how-many-
plants-can-i-have-if-im-on-the-montana-marijuana-registry (last visited 
Feb. 28, 2015). 
Home Grown: Registered cardholders may possess twelve seedlings, 
a seedling being a plant less than twelve-inches tall, and four mature plants. 
Id. 
Dispensaries: No 
Illnesses: Cancer, glaucoma, HIV positive, AIDS, when the condition 
or disease results in debilitating symptoms; wasting syndrome, severe 
chronic pain that interferes with daily activities (must be documented by 
physician), Crohn’s disease, MS, peripheral neuropathy, chronic painful 
muscle spasms, seizure disorders, hard to control nausea, conditions leading 
to hospice care, and other conditions as approved by the legislature. 
Providers and MIPPs: Must be a Montana resident who is eighteen 
years of age or older; must not be in the custody of or under the supervision 
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of the Department of Corrections or a youth court; must not have a felony 
conviction for a drug offense; must not have fraudulently represented self 
as a registered cardholder or MIPP under this Act; must not have failed to 
pay taxes or a judgment to a government agency; must not have defaulted 
on student loans or have failed to pay child support; must not have failed to 
remedy outstanding child support or tax judgments; must reapply annually. 
A provider or MIPP may assist up to three registered cardholders. If the 
provider or MIPP is also a registered cardholder then s/he may assist only 
two additional registered cardholders. MONT. CODE ANN. § 50-46-308; 
MONT. ADMIN. R. 37.107.115 (2011); 




Medical Use of Marijuana, 453A NE. REV. STAT. ANN. §§ 453A.010–
453A.810 (West, Westlaw through the end of the Twenty-Eighth Spec. 
Sess. (2014)). 
Persons in possession of a valid registry identification card are pro-
tected from prosecution for possession, delivery, or production of marijuana 
as well as possession and delivery of related paraphernalia. Additionally, 
protection from prosecution is provided for aiding and abetting in the pos-
session or delivery of marijuana or related paraphernalia in connection with 
a qualifying person. Registration cards are administered by the Division of 
Public and Behavioral Health of the Department of Health and Human Ser-
vices. NEV. REV. STAT. ANN. §§ 453A.200, .210. 
Possession: 2 ½ ounces in any fourteen-day period; twelve marijuana 
plants regardless of maturity and the regulatory permissible amount of edi-
ble marijuana products. NEV. REV. STAT. ANN. § 453A.200. 
Home Grown: No 
Dispensaries: Yes. NEV. REV. STAT. ANN. § 453A.115. 
Illnesses: AIDS, cancer, and glaucoma. A medical condition or treat-
ment therefore, that for a specific patient, results in: cachexia, persistent 
muscle spasms, seizures, severe nausea, or severe pain. Any other condition 
the Division deems chronic or debilitating and a condition approved pursu-
ant to petition. NEV. REV. STAT. ANN. § 453A.050. 
Caregivers: Must be eighteen years of age or older and have signifi-
cant responsibility for the well-being of the person with the qualifying con-
dition. There may be only one designated primary caregiver per person with 
a qualifying medical condition. 
Agency Website: http://www.health.nv.gov/MedicalMarijuana.htm  
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NEW HAMPSHIRE 
Use of Cannabis for Therapeutic Purposes, N.H. REV. STAT. ANN. §§ 126-
X:1 to -X:11 (Lexis through the 2014 Sess.). 
The provisions of this law are administered by the Department of 
Health and Human Services. Protection is provided to qualifying patients 
for the possession and use of cannabis for therapeutic use in compliance 
with the law. Additionally, caregivers possessing an acceptable amount of 
therapeutic cannabis, as stated in the statute, for a qualifying patient are 
protected from prosecution. Valid registry cards from other jurisdictions 
will be honored within the state. Protections are also provided for providers 
of therapeutic cannabis and alternative treatment centers acting in accord-
ance with the law. Qualifying patients who have custody or visitation rights 
will not be presumed to be neglectful or endangering the child(ren) when 
acting in accordance with the law. Additionally, custody or visitation can-
not be denied solely based on conduct in connection to the law. N.H. REV. 
STAT. ANN. §§ 126-X:1, 126-X:2. 
Possession: Two ounces of useable cannabis or any amount of unusa-
ble cannabis. Caregivers may possess two ounces per qualifying patient for 
which s/he is a designated caregiver. N.H. REV. STAT. ANN. §§ 126-X:2 (I), 
(II). 
Homegrown: No. N.H. CODE R. Dep’t of Health and Human Services 
He-C 401.02(m). 
Dispensaries: No 
Illnesses: Cancer, glaucoma, HIV positive, AIDS, hepatitis C when 
antiviral treatment is being done, ALS, muscular dystrophy, Crohn’s dis-
ease, agitation associated with Alzheimer’s, MS, chronic pancreatitis, spinal 
cord injuries or diseases, traumatic brain injury, injur(ies) that significantly 
interfere with daily activity (must be documented by patient’s provider), 
severely debilitating or terminal illness resulting in one or more of the fol-
lowing: elevated intraocular pressure, cachexia, anorexia as a result of 
chemotherapy, wasting syndrome, constant or severe nausea, moderate to 
severe vomiting, seizure, severe muscle spasms, and severe pain not re-
sponding to other treatments or where treatments have serious side effects. 
N.H. REV. STAT. ANN. § 126-X:1(IX); N.H. CODE R. Dep’t of Health and 
Human Services He-C 401.02(j). 
Caregivers: Must be twenty-one years of age or older. Has agreed to 
assist a qualifying patient with the use of therapeutic cannabis. Cannot as-
sist more than five qualifying patients. Must have never been convicted of a 
felony or any felony drug-related offense. Must obtain a valid registry card 
under this law. N.H. REV. STAT. ANN. § 126-X:1(VI). 
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Agency Website: http://www.dhhs.state.nh.us/oos/tcp/  
 
NEW JERSEY 
New Jersey Compassionate Use Medical Marijuana Act, N.J. STAT. ANN. 
§§ 24:6I-1 to -16 (Lexis through the 216th Ann. Sess., L. 2015, c. 
3NJ). 
The purpose of the Act is to “protect from arrest, prosecution, property 
forfeiture, and criminal and other penalties” qualifying patients use of med-
ical marijuana. N.J. STAT. ANN. § 24:6I-2(e). The Act is administered by 
the Department of Health and covers the medical marijuana activities of 
qualifying patients who must be provided a certification by a physician with 
whom s/he has a bona-fide physician-patient relationship. The Department 
of Health issues registry identification cards to qualifying patients. N.J. 
STAT. ANN. § 24:6I-2. 
Possession: Two ounces per thirty-day period. N.J. STAT. ANN. § 
24:6I-10. 
Homegrown: No 
Dispensaries: Alternative Treatment Centers provide medical mariju-
ana based on a physician’s instructions. N.J. STAT. ANN. § 24:6I-10. 
Illnesses: ALS; MS; terminal cancer; muscular dystrophy; inflamma-
tory bowel disease including: Crohn’s disease; terminal illness with a prog-
nosis of less than twelve months to live; one of the following if resistant to 
existing conventional treatment: seizure disorders, intractable skeletal mus-
cular spasticity, or glaucoma; one of the following when severe or chronic 
pain, or sever nausea or vomiting or wasting syndrome result: HIV positive, 
AIDS or cancer; any other condition approved by the Department of Health. 
N.J. STAT. ANN. § 24:6I-3; N.J. ADMIN. CODE § 8:64-1.2 (2015). 
Caregivers: A resident of the state who is eighteen years of age or 
older, has agreed to assist a qualifying patient with the use of medical mari-
juana who is neither a primary caregiver to another qualifying patient, nor 
the patient’s physician, has never been convicted of sale of a controlled 
dangerous substance unless the conviction was at the federal level and per-
tained to lawful behavior under this Act, has properly registered and passed 
the criminal background check and has been designated as primary caregiv-
er on the qualifying patient’s application. N.J. STAT. ANN. § 24:6I-3; N.J. 
ADMIN. CODE § 8:64-2.3 (2015). 
Agency Website: http://www.state.nj.us/health/medicalmarijuana/  
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NEW MEXICO 
Lynn and Erin Compassionate Use Act, N.M. STAT. ANN. §§ 26-2B-1 to -7 
(Lexis through the end of the Second Reg. Sess. of the Fifty-First 
Leg.). 
The law was enacted to permit the use of medical cannabis to alleviate 
symptoms of debilitating medical conditions and treatments in a controlled 
fashion. The Department of Health administers the law. Practitioners, per-
sons licensed to prescribe and administer drugs identified in the Controlled 
Substances Act, determine a patient’s status as a qualified patient. Written 
certifications are not valid for more than one year. Medical cannabis must 
be obtained only from in-state sources. Qualified patients must provide their 
name, address, and birthdate as well as the name, address, and phone num-
ber of their practitioner. N.M. STAT. ANN. §§ 26-2B-2, 26-2B-7; N.M. 
CODE R. § 7.34.2.7 (2015). 
Possession: An adequate three-month supply. An adequate supply 
cannot exceed six ounces of useable cannabis. If a personal production li-
cense is held, four mature plants and twelve seedlings are permitted. If 
treatment is topical, a three-month supply is allowed. Additional amounts 
may be permitted at the Department’s discretion. N.M. CODE R. § 7.34.2.7. 
Homegrown: Permitted after obtaining a personal production license. 
License may also be issued to a primary caregiver. N.M. CODE R. § 
7.34.2.7(AA). 
Dispensaries: Yes 
Illnesses: Cancer, glaucoma, MS, spinal cord damage with objective 
neurological indication of intractable spasticity, epilepsy, HIV positive, 
AIDS, hospice care in accordance with rules of department, and any other 
medical condition, treatment, or disease as approved by the department. 
N.M. STAT. ANN. § 26-2B-3(B). 
Caregivers: Must be a resident of New Mexico who is at least eight-
een years of age, and have been deemed necessary to take care of the pa-
tient’s well-being, by the patient’s practitioner, with respect to the medical 
use of cannabis. N.M. STAT. ANN. § 26-2B-3(F). 
Agency Website: http://nmhealth.org/about/mcp/svcs/  
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NEW YORK 
Compassionate Care Act, N.Y. PUB. HEALTH §§ 3360–3369-e (Lexis 
through 2014 released chs. 1-478). 
Possession, use, acquisition, delivery, transportation, and transfer of 
medical marihuana are lawful under this Act when done by a certified pa-
tient or designated caregiver holding a valid registry identification card and 
in accordance with the law. To be certified, patient must be working with a 
practitioner registered to issue certificates by the commissioner, must have 
a serious condition documented in medical records, the registered practi-
tioner must be qualified to treat patient’s condition, the patient must be un-
der the continuing care of the practitioner, and the practitioner’s view is that 
in looking at past treatments the patient will benefit from the use of medical 
marihuana. N.Y. PUB. HEALTH §§ 3360(1), 3662. 
Possession: A thirty-day supply of the dosage determined by patient’s 
practitioner and that dosage is consistent with regulations by the commis-
sioner. Product must be kept in its original packaging except for that por-
tion being used immediately. N.Y. PUB. HEALTH § 3362. 
Homegrown: No 
Dispensaries: Yes. N.Y. PUB. HEALTH § 3364. 
Illness: Cancer, HIV positive, AIDS, ALS, Parkinson’s disease, MS, 
spinal cord damage with objective neurological indication of intractable 
spasticity, epilepsy, inflammatory bowel disease, neuropathies, Hunting-
ton’s disease, and others as added by the commission. Also covered are the 
following when clinically associated with or a complication of a condition 
in this section: wasting syndrome or cachexia, severe or chronic pain, sever 
nausea, seizures, severe or persistent muscle spasms, and other conditions 
added by the commissioner. Within eighteen months of the effective date of 
the Act, July 3, 2014, the commissioner will make a determination on the 
following: Alzheimer’s, muscular dystrophy, dystonia, PTSD, and rheuma-
toid arthritis. N.Y. PUB. HEALTH § 3360(7). 
Caregivers: Must be designated by the patient. Additional require-
ments are likely forthcoming but the regulations related to this Act have not 
yet been enacted. 
Agency Website: 
https://www.health.ny.gov/regulations/medical_marijuana/  
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OREGON 
Oregon Medical Marijuana Act, OR. REV. STAT. ANN. §§ 475.300–475.346 
(Lexis through the 2014 Sess.). 
Provides protection from civil and criminal penalties for patients using 
medical marijuana on the advice of a doctor and in conformity with stated 
restrictions in the Act. The Oregon Health Authority oversees the Act. The 
authority will issue registry identification cards to qualified patients and/or 
designated primary caregivers. 
Possession: Patient or designated primary caregiver may possess 
twenty-four ounces of useable marijuana, up to six mature plants, and up to 
eighteen seedlings. A one-ounce limitation is placed on patients having 
been convicted of certain Schedule I or II controlled substance offenses. 
Growers may possess the same amounts per patient for whom s/he is a 
grower. A grower may produce for no more than four qualified patients. 
OR. ADMIN. R. 333-008-0080 (2015). 
Homegrown: Yes 
Dispensaries: Yes. OR. REV. STAT. ANN. § 475.314; OR. ADMIN. R. 
333-008-1000-, 333-008-1400 (2015). 
Illnesses: Cancer, glaucoma, agitation related to Alzheimer’s disease, 
HIV positive, AIDS, or side-effects related to the treatment of the afore 
mentioned conditions. Medical treatments or conditions resulting in cachex-
ia, severe pain, severe nausea, seizures, including those caused by epilepsy, 
persistent muscle spasms, including those caused by MS, PTSD, or any 
other condition or side-effect approved by the Authority. OR. REV. STAT. 
ANN. § 475.302(3). 
Caregivers: Designated primary caregivers must be eighteen years of 
age or older, have the significant responsibility for managing the well-being 
of a person with a debilitating medical condition, be designated as such on 
the patient’s registry identification application card, and may not be the 
patient’s physician. OR. REV. STAT. ANN. § 475.302(5). 





The Edward O. Hawkins and Thomas C. Slater Medical Marijuana Act, R.I. 
GEN. LAWS ANN. §§ 21-28.6-1 to -14 (Lexis through Jan. 2014 Sess.). 
The purpose of the Act is to protect from arrest and prosecution, other 
criminal penalties and property forfeiture, patients with debilitating medical 
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conditions, their caregivers, and physicians. Protection is also provided for 
a patient cardholder who grows and sells or distributes marijuana as identi-
fied in the Act to a compassion center cardholder. The Act is administered 
by the Rhode Island Department of Health.  
Possession: 2 ½ ounces of useable marijuana and up to twelve mature 
plants. Plants must be stored indoors. Additionally, up to twelve seedlings 
may be possessed. R.I. GEN. LAWS ANN. §§ 21-28.6-4(a), (d), and (e). 
Homegrown: Permitted. R.I. GEN. LAWS ANN. § 21-28.6-4(a) (pos-
session includes mature and immature plants). 
Dispensaries: Yes, as Compassion Centers. R.I. GEN. LAWS ANN. § 
21-28.6-3(2)(i); 14-035 R.I. CODE R. § 1.2. 
Illnesses: Cancer; glaucoma; HIV positive; AIDS; hepatitis C and 
treatments thereof. Chronic debilitating diseases, medical conditions or 
treatments thereof that result in: cachexia; severe debilitating, chronic pain; 
severe nausea; seizures, including but not limited to those associated with 
epilepsy; sever or persistent muscle spasms, including but not limited to 
those associated with MS or Crohn’s disease; agitation of Alzheimer’s dis-
ease; or any other condition or treatment approved by the department. R.I. 
GEN. LAWS ANN. § 21-28.6-3(3). 
Caregivers: A natural person must be twenty-one years old or older 
and may assist no more than five qualifying patients at once. Caregivers 
may also be compassion centers registered under R.I. GEN. LAWS ANN. § 
21-28.6-12 who have been designated as a primary caregiver by a qualified 
patient. R.I. GEN. LAWS ANN. §§ 21-28.6-3(2)(i), (9); 14-035 R.I. CODE R. 
§§ 1.2, 1.12. 




Therapeutic Use of Cannabis, VT. STAT. ANN. tit. 18, §§ 4471–4474m 
(Lexis through the 2013 adjourned Sess.). 
Provides protection from arrest or prosecution for registered patients 
and their registered caregivers, health care professionals who have partici-
pated in the patient’s application process. To qualify as a registered patient, 
one must be diagnosed with a debilitating disease or condition by a physi-
cian with whom the patient has a bona-fide healthcare professional-patient 
relationship. The Act is administered by the Department of Public Safety.  
Possession: Two ounces of useable marijuana, up to two mature mari-
juana plants, and seven immature plants may be possessed collectively by 
the patient and caregiver. VT. STAT. ANN. tit. 18, § 4472(10). 
Homegrown: Permitted. 
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Dispensaries: Yes. VT. STAT. ANN. tit. 18, §§ 4474e–4474i. 
Illnesses: Cancer, MS, HIV positive, AIDS or the treatment of the 
aforementioned conditions if the disease or treatment thereof results in se-
vere, persistent, and intractable symptoms; chronic or debilitating diseases 
resulting in cachexia, severe pain, severe nausea, or seizures. VT. STAT. 
ANN. tit. 18, § 4472(4); 28-003 VT. CODE R. § 3. 
Caregivers: Must be twenty-one years of age or older, never been 
convicted of a drug related crime, been issued a registration card by the 
Department of Public Safety, and has agreed to be responsible for the medi-
cal marijuana use related well-being of a registered patient. VT. STAT. ANN. 
tit. 18, § 4472(11); 28-003 VT. CODE R. § 1.12. 
Agency Website: http://vcic.vermont.gov/marijuana_registry  
 
WASHINGTON  
Medical Cannabis, WASH. REV. CODE ANN. §§ 69.51A.005–69.51A.903 
(Lexis through the 2014 Reg. Sess. and the 2014 Gen. Election). 
Provides protection from arrest, prosecution, or other state criminal or 
civil consequences when lawfully using medical marijuana in compliance 
with the law. Also protected are designated providers and health care pro-
fessionals working within the parameters of the medical marijuana laws. 
Qualifying patients must be residents of the state of Washington at the time 
of the diagnosis of their terminal or debilitating medical condition. 
Possession: No more than fifteen cannabis plants; twenty-four ounces 
of useable cannabis; cannabis product only in an amount that could be made 
with twenty-four ounces of cannabis, or a combination of useable cannabis 
and cannabis product. A person who is both a qualifying patient and a des-
ignated provider may possess two times the aforementioned amounts. 
WASH. REV. CODE ANN. § 69.51A.040. 
Homegrown: Yes. WASH. REV. CODE ANN. § 69.51A.040. 
Dispensaries: Yes. WASH. ADMIN CODE §§ 314-55-005 through 314-
55-540 (2015). 
Illnesses: Cancer, HIV, MS, epilepsy or other seizure disorder, spas-
ticity disorders, intractable pain (pain that is not relieved by standard treat-
ments), glaucoma (pain form which is not relieved by standard treatments), 
Crohn’s disease (debilitating symptoms of which are not relieved by stand-
ard treatments), hepatitis C (where debilitating nausea or intractable pain 
are not relieved by standard treatment), diseases, where symptoms are not 
relieved by standard treatment, including nausea from anorexia, vomiting, 
wasting, appetite loss, cramping, seizures, muscle spasms or spasticity, and 
any other medical condition approved by the Washington State Medical 
Quality Assurance Commission. WASH. REV. CODE ANN. § 69.51A.010(4). 
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Caregivers:  Is eighteen years of age or older, designated in writing 
by the patient to be the designated provider, is prohibited from consuming 
the medical marijuana that is intended for medical use by the patient, and 






THE UNITED STATES SUPREME COURT AND MEDICAL MARIJUANA USE 
UNDER THE CONTROLLED SUBSTANCES ACT 
Gonzales v. Raich, 545 U.S. 1 (2004).  
 
The United States Supreme Court in Gonzales v. Raich determined 
that the Comprehensive Drug Abuse Prevention and Control Act of 1970 
(commonly referred to as the Controlled Substances Act) had constitutional 
supremacy over state laws allowing medical marijuana use. Thus, individu-
als using medical marijuana were not protected from federal prosecutions. 
The case arose out of California. The respondents in the case were Califor-
nia residents suffering from serious medical conditions. In order to alleviate 
symptoms associated with these conditions they were using medical mari-
juana under the California Compassionate Use Act. Gonzales, 545 U.S. at 
6. Respondent Monson cultivated her own marijuana and Respondent Raich 
was provided with medical marijuana by two registered caregivers. Id. at 7. 
In August 2002, federal agents seized and destroyed the marijuana plants in 
Monson’s home. Id. at 8. Raich’s home was never entered by federal 
agents, however she feared this could happen at any time. Raich v. Ashcroft, 
248 F. Supp. 2d 921 (N.D. Cal. 2003). The United States Supreme Court 
stated the issue as follows: “whether Congress’ power to regulate interstate 
markets for medicinal substances encompasses the portions of those mar-
kets that are supplied with drugs produced and consumed locally.” Gonza-
les, 545 U.S. at 9. While the Court acknowledged the “troubling facts” of 
the case at hand, it found that the Controlled Substances Act was a “valid 
exercise of federal power.” Id. at 9. 
 
RECENT CONGRESSIONAL ACTIONS 
The U.S. House and Senate both recently introduced bills that would 
end the long-standing conflict between state and federal laws with respect 
to medical marijuana. The Regulate Marijuana Like Alcohol Act, H.R. 
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1013, 114th Cong. (2015), introduced in the United States House of Repre-
sentatives on February 20, 2015, and The Compassionate Access, Research 
Expansion and Respect States Act, S. 683, 114th Cong. (2015), introduced 
in the United States Senate on March, 10, 2015, would reschedule marijua-
na from Schedule I classification to Schedule II under the Controlled Sub-
stances Act, thus recognizing it for medical use.   
 
ARTICLES 
The following materials represent a select group of articles addressing 
medical marijuana in different areas including employment, federalism, 
family law, and transportation. Also included in this section is a summary 
of the Department of Justice’s memorandums addressing federal enforce-
ment issues. Intermixed are additional statutory and case law summaries 
when connected to the article topics. 
 
FEDERALISM AND MEDICAL MARIJUANA  
Gerald Caplan, Medical Marijuana: A Study of Unintended Consequences, 
43 MCGEORGE L. REV. 127 (2012).  
 
This Article highlights the evolution of medical marijuana laws in 
Colorado, California, and Michigan. Noted is that the initial applications for 
use in these states were on the low end with numbers increasing dramatical-
ly after the 2009 statement from the Obama administration. The statement 
was interpreted as stating individuals in compliance with state law would 
not be arrested under federal law. For example, in Colorado, from January 
2009 to January 2010, there was an 871% increase in registrants for medi-
cal marijuana use under the state law. Also noted is the lack of consistency 
in some jurisdictions with respect to certain aspects of the laws. In Califor-
nia, the amount of medical marijuana that a person may possess varies by 
county. State law says up to eight ounces may be possessed; yet a signifi-
cantly higher amount is allowed in some counties. In Michigan, as in other 
states, the author notes that a small number of physicians certify a signifi-
cant number of patients for medical marijuana use. Mr. Caplan stated that 
the original thought with respect to medical marijuana was that a small 
number of older adults with debilitating conditions would use medical mari-
juana. Very few patients would be under the age of forty, and marijuana use 
would not be permitted for conditions that were hard to verify such as stress 
and anxiety. The author however indicates that this has not been the prac-
tice in many jurisdictions, and in some areas, physicians are in practice only 
to see patients wanting to qualify for medical marijuana use. He indicates 
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how this practice is very different from the usual doctor-patient relation-
ship. The author also discussed the increased number of dispensaries and 
how many are very involved in marketing their businesses. Mr. Caplan ends 
with a discussion of law enforcement issues related to the new medical ma-
rijuana programs and the broader effects of additional states legalizing the 
recreational use of marijuana. 
 
Erwin Chemerinsky et al., Cooperative Federalism and Marijuana Regula-
tions, 62 UCLA L. REV. 74 (2015). 
 
The authors propose a solution to the federalism issue with respect to 
the Controlled Substances Act and marijuana. The proposed solution in-
volves permitting states wishing to legalize marijuana an opportunity to 
opt-out of Controlled Substances Act provisions related to marijuana as 
long as the states meet specified criteria. The history of marijuana is cov-
ered starting with some states criminalizing the drug in the 1910s through 
the recent Department of Justice’s response to Colorado and Washington 
legalizing the recreational use of marijuana. The authors then proceed to 
address the problems that the federal criminalization of the drug poses to 
businesses and those seeking to use marijuana legally. Topics covered in-
clude the need for a marijuana business to be cash only due to banking laws 
that threaten prosecution for money laundering. Also covered is the prob-
lem with federal taxes and the exorbitant amounts that must be paid by “il-
legal” entities. A provision of the Internal Revenue Code requires an entity 
operating in violation of federal drug laws to pay a tax that creates a signifi-
cant disadvantage to the entity–e.g., not being able to deduct business ex-
penses from income. A third challenge covered is the availability of lawyers 
able and willing to provide services. Fourth, the authors look at the conse-
quences of those using legalized marijuana, in an employment situation, 
individuals on parole and with a probation status, and in family law situa-
tions. The next area analyzed is the federal preemption law with respect to 
the Controlled Substances Act and the anti-commandeering doctrine of the 
Tenth Amendment. Section 903 of the Controlled Substances Act is dis-
cussed in that the authors indicate it shows Congress’s intent not to com-
pletely preempt the regulation of controlled substances in the Controlled 
Substances Act. Lastly, the authors discuss crafting federal laws to work 
with state marijuana laws by employing cooperative federalism. 
 
Todd Grabarsky, Conflicting Federal and State Medical Marijuana Poli-
cies: A Threat to Cooperative Federalism, 116 W. VA. L. REV. 1 (2013). 
 
The author intends to explain the zone in which marijuana related ac-
tivities can be both legal and illegal. In doing so he states that the enforce-
ment of federal drug laws in an unpredictable manner can threaten the ef-
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fectiveness and cooperative efforts of federal and state authorities in enforc-
ing “dual-ban” drug laws. Mr. Grabarsky summarizes the Department of 
Justice memorandums and the changing landscape in legalized marijuana 
with two states recently voting to legalize its recreational use. His main 
focus though is on the conflict between federal law and California’s Com-
passionate Use Act. The author summarizes the California law and the state 
case law that evolved in relation to the Act. He then discusses the Con-
trolled Substances Act and Congress’s and the Drug Enforcement Agency’s 
inaction in rescheduling marijuana. In a section on de jure constitutional 
authority, the author discusses commandeering, preemption, and condition-
al spending. He also addresses the obstacles to the federal enforcement of 
marijuana violations. The author next discusses the change in federal en-
forcement and the crackdown on medical marijuana entities profiting from 
the sale of medical marijuana whereby distributors in California were 
closed and dispensaries received cease and desist letters. The author dis-
cusses how these activities threatened cooperative federalism and also ad-
dresses the idea with respect to those states authorizing recreational use of 
marijuana. The author next discusses the idea of creating an exemption for 
persons and entities complying with state laws and the viability of such a 
system. 
 
Troy E. Grandel, One Toke Over the Line: The Proliferation of State Medi-
cal Marijuana Laws, 9 U. N.H. L. REV. 135 (2010-2011). 
 
Mr. Grandel approaches his article acknowledging that he is making 
the assumption that there are valid medicinal qualities associated with mari-
juana. He provides a discussion of the changing view toward marijuana in 
the 1930s from a medicinal product to one associated with drug use and 
deviance. He then summarizes the start of the “war on drugs” in the 1970s 
and the Comprehensive Drug Abuse Prevention and Control Act. A brief 
look is taken at the 1980s action creating a drug czar. The author then be-
gins a look at California in the 1990s and other states, in subsequent years, 
enacting medical marijuana laws. Mr. Grandel summarizes the votes in 
each state legalizing medical marijuana. He also identifies the condi-
tion/diseases for which medical marijuana can be used. Other issues ad-
dressed are the problem employees may face in the workplace when proper-
ly using medical marijuana and the fact that marijuana is an agricultural 
crop having a stand-alone value. 
 
Robert A. Mikos, Preemption Under the Controlled Substances Act, 16 J. 
HEALTH CARE L. & POL’Y 5 (2013). 
 
The author identifies the significant confusion and various interpreta-
tions of courts relating to states’ adoptions of the legalization of medical, 
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and in some instances recreational, marijuana use. He notes that states have 
differed on issues such as the ability to license marijuana distributors noting 
that even courts within a single state have reached different conclusions on 
this issue. In this Article, Mr. Mikos proposes a direct conflict test where 
“state law is preempted only if it requires someone to violate federal law.” 
He provides a general discussion of preemption, including field preemption, 
direct conflicts, and obstacle conflicts. Additionally, preemption with re-
spect to the Controlled Substances Act is addressed and the language of 
section 903 is evaluated and its application in cases where the courts inter-
preted it to mean the Controlled Substances Act preempted all state law 
conflicts. In discussing the reasons the obstacle conflict preemption rule is 
too broad, the author covers differences between legalization and regulation 
and why that distinction is important in the medical marijuana discussion. 
Another factor presented by the author is the concept that Congress intend-
ed to preempt the creation of regulations that promote rather than restrict 
marijuana activities. He uses examples such as state subsidies for medical 
marijuana being preempted as such action would drive the cost down and 
thus promote marijuana use, whereas licensing, taxing or requiring registra-
tion would add to the cost of marijuana, at least minimally, thus restricting 
the activities. The author goes on to argue the benefits of a direct conflict 
rule, starting with how such a rule would help courts avoid the comman-
deering trap, permit them to not preempt regulations that place restrictions 
on the marijuana market, and to permit state laws that are only indirectly 
affecting the actions of Congress. Mr. Mikos proceeds to analyze state laws 
that may pose a direct conflict to the Controlled Substances Act and sepa-
rates these laws into those legalizing marijuana related activities as well as 
those that promote marijuana related activities. He indicates in his analysis 
that only a few states have laws that are in direct conflict with the Con-
trolled Substances Act. 
 
Michael D. Ramsey, American Federalism and the Tragedy of Gonzales v. 
Raich, 31 U. QUEENSLAND L.J. 203 (2012). 
 
The author states that the decision in Gonzales v. Raich was the “U.S. 
Supreme Court’s worst modern decision.” Id. at 203. In support of his 
stance, he identifies four propositions: 1) the shocking implausibility of 
Gonzales v. Raich; 2) Gonzales v. Raich involves “a matter . . . that is core 
to the U.S. constitutional system . . . .” Id. at 203; 3) Raich came at a time 
of reinvigoration of federalism and offered the opportunity for expansion of 
judicial protection of federalism; and 4) Raich undercut the attempt to re-
turn to stronger federalism. In his essay, Mr. Ramsey provides a history of 
federalism beginning with the birth of the United States. He continues with 
a revival of it in the 1990s with the case of Gregory v. Ashcroft, 501 U.S. 
452 (1991). The author notes his observation of a movement away from 
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federalism as intended in the Constitution but prior to Raich saw a move-
ment to “rectify the constitutional departures.” Id. at 224. The author notes 
changes in the Court once again affected the federalism issue and its direc-
tion.  
 
David S. Schwartz, Presidential Politics as a Safeguard of Federalism: The 
Case of Marijuana Legalization, 62 BUFF. L. REV. 599 (2014). 
 
Mr. Schwartz discusses the movement of the Court between the non-
deferential and deferential review of federalism, noting that the non-
deferential view in the Lochner era and the deferential view applied in the 
1930s and early 1940s as a “substantial effects” test. Also covered is the use 
of the Tenth Amendment in the federalism discussions. The author address-
es the “political safeguards of federalism” theory and the idea that Congress 
and the President are better situated to strike a national versus local regula-
tory balance. The origin of the phrase “political safeguards of federalism” 
and Professor Herbert Wechsler’s article are discussed. He follows with a 
discussion of weaknesses in the theory noted by Professor Larry Kramer. A 
position the author notes, of Kramer, is that state autonomy is protected by 
party politics. The author also references the 2013 article by Robert Mikos 
discussing the “under-enforcement” of the federal law and hypothesizes 
that the actual policy of the Obama administration leads to this under-
enforcement. Mr. Schwartz identifies marijuana regulation as “one of the 
most complex regulatory problems in the history of federalism.” In discuss-
ing this problem the author covers state’s legalization of marijuana and then 
addresses the Controlled Substances Act, the Supremacy Clause indicating 
state laws may not supersede federal laws (preemption), and the impact of 
state legalization on federal law enforcement. Additionally, he addresses 
the lack of action on behalf of Congress or the Attorney General to re-
schedule marijuana. The author moves into a discussion of the Electoral 
College and swing state votes when a group of swing states hold a political 
or social idea that is different from the national policy view on the same 
topic. Of the twenty states with legalized medical marijuana the author 
identifies thirteen of them as potential swing states. He then proceeds to 
discuss drug policies and presidential campaigns followed by an analysis of 
what each branch of government can do to protect federalism in some in-
stances. 
 
Vijay Sekhon, Highly Uncertain Times: An Analysis of the Executive 
Branch’s Decision to not Investigate or Prosecute Individuals in Compli-
ance with State Medical Marijuana Laws, 37 HASTINGS CONST. L.Q. 553 
(2009-2010). 
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The author addresses the efficacy of President Obama and Attorney 
General Eric Holder’s position to not enforce federal drug laws against the 
legalized use of medical marijuana in light of the Separation of Powers 
clause of the United States Constitution. The author states that the enforce-
ment policy is in direct conflict with the Controlled Substances Act (CSA), 
and the decision to not enforce in these instances must be drawn from pros-
ecutorial discretion. He indicates this is supported by a memorandum from 
the Deputy Attorney General of the United States Department of Justice. In 
his analysis he looks at the Wayte case and identifies why the concerns re-
garding judicial review in that case are not the same when applied to the 
decision not to enforce federal laws in medical marijuana cases. Because of 
the doctrine of sovereign immunity the author cautions against being too 
comfortable with safety from compliance with state laws thus resulting in 
protection based on the Executive Branch’s stated enforcement policy. He 
writes that an individual citizen cannot sue the government without the 
government’s permission–the government has qualified immunity–thus an 
individual qualified in his or her state to use medical marijuana cannot chal-
lenge the Executive Branch’s enforcement position if that individual is ar-
rested and charged under federal drug laws. However, Congress is not pro-
hibited from suing to remove the enforcement policy. In order to remove 
the uncertainties faced by those operating under the rights given to them by 
state law, the author urges Congress to pass and the President to sign legis-
lation codifying the enforcement policy regarding the use of medical mari-
juana in compliance with state laws. 
 
EMPLOYMENT ISSUES ASSOCIATED WITH MEDICAL 
MARIJUANA 
Francine Bailey, Reefer Madness: Lighting Up in the Dairyland, WIS. 
LAW., Nov. 2014, at 24. 
 
This Article examines whether or not Wisconsin employers may ter-
minate employees for using recreational marijuana in states where recrea-
tional marijuana is permitted. The author argues that Wisconsin currently 
does not permit the use of recreational marijuana or provide protections for 
medical marijuana users; given the drug’s popularity, it is highly likely that 
many Wisconsin employees are using marijuana when off duty. She notes 
that Wisconsin courts have not addressed either medical marijuana or legal-
ized recreational marijuana. However, she explores the legislation in Colo-
rado and Washington that permit the recreational use of marijuana. She also 
discusses the growth in “pot tourism” in these states. Finally, she looks at 
current case law with regards to medical marijuana in the workplace, and 
how a Wisconsin court might rule in an employment case involving legal 
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recreational marijuana. She concludes that it is likely a court would use the 
reasoning courts have adopted in the medical marijuana cases. Therefore, it 
is unlikely that a Wisconsin employee would prevail in an employment case 
where the employee is terminated for using legal recreational marijuana in 
another state.  
 
Jay S. Becker & Saranne E. Weimer, Legalization of Marijuana Raises 
Significant Questions and Issues for Employers, N.J. LAW., Dec. 2014, at 
66. 
 
This Article examines employers’ potential obligations in states where 
medical marijuana is legal. First, the Article discusses the legal conundrum 
that will exist so long as the federal government continues to classify mari-
juana as an illegal drug. In addition, the Article looks at whether or not em-
ployers must provide medical marijuana users an accommodation under the 
Americans with Disabilities Act. It concludes that under federal law there is 
no requirement. However, under some state statutes, the answer is not as 
simple. The Article provides case examples from around the country where 
different courts have examined this issue. It also discusses the challenges of 
providing an accommodation as well as issues associated with medical ma-
rijuana and workers’ compensation and health insurance.   
 
Lori A. Bowman & Jonathan S. Longino, Taking the High Road-The 
Healthcare Provider’s Duty to Accommodate Employees’ Medical Mariju-
ana Use, 5 J. HEALTH & LIFE SCI. 34 (2012). 
 
This Article examines the legal landscape for healthcare providers 
when it comes to accommodating bona fide medical marijuana users who 
also happen to be healthcare providers. Here, the authors trace the growth 
of the medical marijuana industry. Then, they look at the inconsistencies 
between state and federal law with regards to medical marijuana and pro-
tection from criminal prosecution. Next, they shift to the employment law 
arena by looking at whether there is a duty to accommodate medical mari-
juana users under the Americans with Disabilities Act (ADA). They ulti-
mately conclude that there is not, since the ADA is directly tied to the Con-
trolled Substances Act (CSA). They turn to state laws and look at two ap-
proaches—the no accommodation approach and the no discrimination ap-
proach. The no accommodation approach refers to state medical marijuana 
laws that make a specific reference in the statute that employers are not 
required to accommodate medical marijuana. For this discussion they ex-
amine the California, Oregon, and Washington statutes. The no discrimina-
tion approach refers to state medical marijuana laws that provide protec-
tions to employees who are bona fide medical marijuana users. For this 
discussion they examine the Rhode Island, Maine, and Arizona statutes. 
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Finally, they examine the special health and safety issues that a healthcare 
provider faces when it comes to medical marijuana and its employees. They 
conclude with several recommendations for health care provider employers. 
 
John Campbell, Coats v. Dish: A Chance to Clear the Legal Haze Sur-
rounding Medical Marijuana, 91 DENV. U. L. REV. ONLINE 79 (2014). 
 
This Article examines the history of medical marijuana in Colorado 
and the current state of the law. It explains that while the medical marijuana 
statute has been on the books for ten years, the Colorado Supreme Court 
has not weighed in on medical marijuana’s lawfulness. It suggests that this 
is likely to change in 2015, because the Court has agreed to hear an em-
ployment case (Coats v. Dish Network LLC) where it is likely to determine 
whether or not medical marijuana is indeed lawful in Colorado. The rest of 
the Article examines Colorado’s law, the case law associated with the law, 
the facts and status of the Coats case, and how the case could be decided.  
 
Holli L. Hartman, Legalized Marijuana and the Workplace: Preparing for 
the Trend, 38 EMP. REL. L.J. 4, Spring 2013, at 72.  
 
This Article examines the legal landscape for employers located in 
states with medical marijuana statutes. Ultimately, the author recommends 
taking a proactive approach by reviewing and revising employment policies 
and handbooks. The author discusses the decriminalization of medical mari-
juana on the state level as well as the federal government's current approach 
to criminal enforcement. She explores the fact that the federal approach has 
largely affected the state courts’ approach to medical marijuana in the 
workplace. She provides a brief analysis of current case law. Then, she 
concludes with recommendations for employers. She argues for employers 
to clearly state their approach to medical marijuana in employment policies 
and procedures. She suggests that this may cut down on litigation because 
employees will know up front where they stand with regards to their em-
ployment and the use of medical marijuana. 
 
Stacy A. Hickox, Drug Testing of Medical Marijuana Users in the Work-
place: An Inaccurate Test of Impairment, 29 HOFSTRA LAB. & EMP. L.J. 
273 (2012).  
 
This Article examines the use of urinalysis tests to take adverse em-
ployment actions against employees who are impaired in the workplace. 
She argues that the reliance on this type of testing is inaccurate and unrelia-
ble when it comes to bona fide medical marijuana users. The author gives 
an overview of the existing medical marijuana statutes and the fact that 
most of these statutes provide language specifying that employers do not 
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have an obligation to accommodate medical marijuana in the work place. 
But, many of those statutes do not contemplate off-duty legal medical mari-
juana use. Then, she explores research discussing marijuana’s effect on 
users and the fact that there is no clear guidance for when a medical mariju-
ana user should be protected from termination based on intoxication or im-
pairment. Next, she examines whether traditional drug tests are appropriate 
for determining whether or not an employee is impaired or intoxicated in 
the workplace. Finally, she offers two solutions to the problem of inaccu-
rate results. She suggests adopting either the approach that criminal courts 
take with regard to intoxication, or the approach that is used in worker’s 
compensation cases. Essentially, she argues that when employers take ad-
verse actions based on impairment, employers should look at whether or not 
the employee is truly affected by marijuana while on duty, not the results of 
a urinalysis test.  
 
Matthew D. Macy, Employment Law and Medical Marijuana—An Uncer-
tain Relationship, 41 COLO. LAW. 57 (2012). 
 
This Article examines how medical marijuana laws have created new 
issues in the employment law arena and some uncertainty for employers. It 
explores the split between federal and state law. Then, it looks at how the 
case law is slowly developing in states with medical marijuana statutes. The 
author points out that while there is relatively little case law, the case law 
that does exist seems to favor employers. He explores several different ar-
guments that have been brought and have failed. He looks at the Americans 
with Disabilities Act and then surveys related state laws in Colorado and 
Oregon. Next, he explores Colorado’s anti-discrimination and lawful acts 
statutes. He concludes that these statutes also will not likely protect an em-
ployee who is also a bona fide medical marijuana user. Finally, he explores 
the strength of public policy arguments in wrongful discharge claims and 
concludes that these arguments will also likely fail. The underlying cause of 
all these arguments failing is the split between federal and state law with 
regards to how marijuana is classified. He also argues that the state statutes 
were intended to protect people from criminal prosecution, and the em-
ployment law ramifications were either not contemplated or legislatures did 
not intend to grant that type of protection. 
 
McGuire Woods, But I have a Prescription!–Employee Drug Tests in the 
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This Article examines ADA considerations that must be made when an 
employer issues discipline to its employees for using medical marijuana. 
The Article points out that the ADA does not protect employees from the 
“illegal use of drugs.” However, if there is an adverse employment action 
associated with a qualified individual with a disability using medical mari-
juana, the employer must be able to show the motivating factor for the ad-
verse action was not the employee’s disability. In addition, the Article pro-
vides a list of recommendations for employers to take to minimize their 
risks for lawsuits.   
 
Michael D. Moberly & Charitie L. Hartsig, Smoke—And Mirrors? Employ-
ers and the Arizona Medical Marijuana Act, ARIZ. ATTORNEY, July-Aug. 
2011, at 30. 
 
This Article examines the managerial and legal problems Arizona em-
ployers face in light of the state’s medical marijuana statute. First, the au-
thors explore the state level decriminalization of medical marijuana. They 
point out that nearly all the medical marijuana statutes are silent to the em-
ployment issues associated with this decriminalization. However, Arizona’s 
statute provides specific language prohibiting employers from discriminat-
ing against medical marijuana users in hiring, promotion, or other terms and 
conditions of employment. The authors discuss some of the potential issues 
this statute creates because it fails to define “impairment.” They explore the 
problem with complying with federal laws and regulations, such as the Oc-
cupational Health and Safety Administration’s regulations governing work-
place safety. They argue that until Arizona’s Department of Health Services 
defines “impairment” employers will be operating in an uncertain area and 
should proceed with caution.  
 
Amy Komoroski Wiwi & Nicole P. Crifo, The Unintended Impact of New 
Jersey’s New Medical Marijuana Law on the Workplace, 36 EMP. REL. L.J., 
Summer 2010, at 33. 
 
This Article examines the implications of New Jersey’s medical mari-
juana statute on New Jersey workplaces. The New Jersey statute is similar 
to many of the other state statutes in that it decriminalizes medical marijua-
na use, but it is silent as to workplace implications such as drug testing and 
drug use policies. However, the statute does provide that employers are not 
required “to accommodate the medical use of marijuana in any workplace.” 
The Article pays particular attention to employers considering accommo-
dating medical marijuana. The authors suggest that there are three im-
portant things to consider: whether an accommodation is appropriate for the 
particular workplace, whether an accommodation will trigger liability under 
anti-disability discrimination laws, and whether there is an ability to verify 
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registry status. Finally, the authors provide a list of recommendations for 
employers who opt to accommodate medical marijuana in the workplace.  
 
STATE STATUTES THAT PROVIDE PROTECTION TO EMPLOYEES 
USING MEDICAL MARIJUANA  
The following is a sampling of state statutes that provide protection to 
employees using medical marijuana. The first state to pass this type of anti-
discrimination statute was Rhode Island. The state’s medical marijuana 
statute specifically prohibits employers from penalizing employees for be-
ing medical marijuana cardholders. Maine also prohibits employers from 
discriminating against employees who are registered medical marijuana 
users. Arizona and Delaware’s statutes use stronger language. The Arizona 
law implies that employers will be barred from disciplining employees for 
using or limiting use of off-duty medical marijuana, while the Delaware 
statute states that employers may not discriminate against medical marijua-
na users in hiring, terminating, or in other terms or conditions of employ-
ment. Moreover, an employer may not terminate a medical marijuana user 
for a positive drug test, unless the employee was using on the job. 
 
R.I. GEN LAWS § 21-28.6-4(b) (West, Westlaw through chapter 555 of 
the Jan. 2014 Sess.). 
 
ME. REV. STAT. tit. 22, § 2423-E(3) (West, Westlaw through 2015 
First Reg. Sess. of the 127th Leg.). 
 
ARIZ. REV. STAT ANN. § 36-2813(B) (West, Westlaw through legis. ef-
fective Feb. 24, 2015 of the First Reg. Sess. of the Fifty-Second Leg.). 
 
DEL. CODE ANN. tit. 16, § 4905A(a)(3) (West, Westlaw through 80 
Laws 2015). 
 
THE STATE COURTS WEIGH IN ON MEDICAL MARIJUANA AND 
THE WORKPLACE 
Coats v. Dish Network, L.L.C., 303 P.3d 147 (Colo. App. 2013), cert. 
granted, No. 13SC394, 2014 WL 279960 (Colo. Jan. 27, 2014). 
 
In this case, the court examined whether an employer is prohibited 
from discharging employees for off-the-job use of medical marijuana. Here, 
Coats filed suit after he was terminated for violating Dish Network’s drug 
policy. Coats, a quadriplegic, was a licensed Colorado medical marijuana 
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user. He used marijuana within the limits of the license and he was never 
under the influence at work. However, he tested positive for marijuana and 
this constituted a violation of Dish Network’s policy. 
To makes its decision, the court examined Colorado’s “Lawful Activi-
ties Statute.” Under the statute, employers are prohibited from terminating 
employees for engaging in lawful activities off hours. Here, the court had to 
decide whether medical marijuana was considered “unlawful.” After exam-
ining the legislative history, the court ultimately concluded that the statute 
did not contemplate protections for a federally prohibited off-the-job activi-
ty. Therefore, employers are not barred from enforcing drug policies with 
regards to medical marijuana. 
The Colorado Supreme Court has granted certiorari and will hear the 
case sometime this year.  
 
Roe v. Teletech Customer Care Mgmt., 257 P.3d 586 (Wash. 2011). 
 
In this case, the court looked at whether or not the Washington State 
Medical Use of Marijuana Act protects employees from adverse employ-
ment actions with regards to employee use of medical marijuana. Here, Roe 
was a bona fide medical marijuana user, who only ingested marijuana in her 
home during off-duty hours. In 2006, Roe was offered a position with Tele-
tech contingent on the results of a drug-screening test. Roe informed the 
company of her medical marijuana use and took the drug test. After taking 
the test, she began her employment training. Shortly thereafter the company 
received the results of the drug test, which she failed. Upon receiving the 
results, Roe was terminated. 
To make its decision, the court examined the state’s medical marijuana 
statute. The court noted that the only reference to employment was “nothing 
in this chapter requires any accommodation of any on-site medical use of 
marijuana in any place of employment.” Looking at the statutory language, 
on its face, the court concluded that the statute was not intended to protect 
an employee from discharge because of medical marijuana use—even if the 
use occurred off-duty. Employers were still entitled to use mandatory drug 
tests as a condition of employment. The court also noted that Washington 
patients have no legal right to use marijuana under federal law, therefore a 
public policy argument fails because the activity is illegal.  
 
Emerald Steel Fabricators v. Bureau of Labor & Indus., 230 P.3d 518 
(Or. 2010). 
 
In this case, the court examined whether under the state’s disability 
statute employers had an affirmative duty to accommodate medical mariju-
ana. Here, the employee in question began using medical marijuana in 
2002. The employee complied with all the provisions in the state’s medical 
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marijuana statute. In 2003, Emerald Steel Fabricators (Emerald) hired em-
ployee on a temporary basis. During this time, employee continued to in-
gest medical marijuana off-duty. Knowing that Emerald was considering 
making the position permanent, the employee told his supervisor about his 
medical marijuana use. One week later, the employee was terminated. 
To make its decision, the court considered how the federal laws inter-
sected with the state laws. Ultimately, the court concluded that there is no 
duty to confer with a disabled employee about his marijuana use, because 
under federal law marijuana use is illegal. Moreover, the court concluded 
that the federal Controlled Substances Act preempts the state’s disability 
statute.  
 
Ross v. RagingWire Telecomm., Inc., 174 P.3d 200 (Cal. 2008). 
 
In this case, the court considered whether under the state’s medical 
marijuana statute employers are required to permit its employees to use 
medical marijuana, and whether employers must accommodate medical 
marijuana use. Here, Ross was a bona fide medical marijuana user. He in-
gested marijuana to alleviate pain from injuries he sustained during active 
military duty. However, he was terminated from his new position at Rag-
ingWire Telecommunications (RagingWire) for failing a pre-employment 
drug test. 
To make its decision, the court considered that the state’s medical ma-
rijuana statute required RagingWire to permit Ross to continue his medical 
marijuana use. First, the court determined that the state’s medical marijuana 
statute only applied to criminal protections. Second, the court determined 
that the statute only specifically addressed on-site accommodations, and the 
statute was silent to off-sight use, therefore it did not cover off-site use and 
accommodation.  
 
THE FEDERAL COURTS WEIGH IN ON MEDICAL MARIJUANA 
AND THE WORKPLACE 
Casias v. Wal-Mart Stores, Inc., 695 F.3d 428 (6th Cir. 2012). 
 
In this case, the court considered whether or not Michigan’s medical 
marijuana statute prevented Michigan employers from terminating employ-
ees for testing positive for marijuana in violation of a company drug policy. 
Here, Casias was a bona fide medical marijuana user. He ingested marijua-
na to alleviate the pain associated with his cancer. In 2009, he was injured 
on the job. This injury was not associated with his marijuana use. Due to 
the on-the-job injury, Casias was required to take a drug test before return-
ing to work. He informed the testing staff that he was a registered medical 
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marijuana user. Then he took the drug test and failed it. Upon receiving the 
results, Wal-Mart terminated his employment. 
The court ultimately decided that the statute did not prevent employers 
from enforcing their drug policies. The court reasoned that the statute was 
intended to protect against criminal prosecution, not adverse employment 
actions.      
 
THE DEPARTMENT OF TRANSPORTATION WEIGHS IN ON 
MEDICAL MARIJUANA AND THE WORKPLACE 
DOT Office of Drug and Alcohol Policy and Compliance Notice 
(Oct. 22 2009), 
http://www.dot.gov/sites/dot.dev/files/docs/ODAPC_medicalmarijuana
notice_0.pdf.  
The Department of Transportation issued a notice informing employ-
ers that state medical marijuana laws do not supersede federal law. There-
fore, employers in the trucking, railroad, airline and transit system indus-
tries must follow the federal regulations with regards to drug testing. And, 
if an employee who uses medical marijuana tests positive, the employer is 
still required to follow the agency regulations with regards to the positive 
drug test. 
 
DEPARTMENT OF JUSTICE APPROACH TO MEDICAL 
MARIJUANA 
Memorandum from David W. Ogden, Deputy Attorney General, 




This is the first memorandum issued by the Department of Justice with 
regards to medical marijuana. It explains that the Department is adopting a 
policy where it will focus enforcement activity on “significant traffickers 
and trafficking networks,” not individuals suffering from debilitating dis-
eases, such as cancer. 
 
Memorandum from James M. Cole, Deputy Attorney General, 
For U.S. Attorneys (Jun. 29, 2011), available at 
http://www.mpp.org/assets/pdfs/library/Cole-memo.pdf. 
 
This is the second memorandum issued by the Department of Justice 
with regards to medical marijuana. Here, the Department takes the position 
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that it is still committed to enforcing the Controlled Substances Act. This 
memo outlines that it was not the Department’s intention to protect large-
scale cultivators from federal prosecution. Rather, the first memorandum 
was merely intended to protect users of medical marijuana, and to ensure 
that federal resources were directed to large-scale operations. 
 
Memorandum from James M. Cole, Deputy Attorney General, 
For U.S. Attorneys (Aug. 29, 2013), available at 
http://www.justice.gov/iso/opa/resources/3052013829132756857467.pdf. 
 
This is the third memorandum issued by the Department of Justice 
with regards to medical marijuana. Here, the Department once again reiter-
ated its priorities with regards to medical marijuana and enforcing the Con-
trolled Substance Act. The memorandum outlines several areas that the 
Department is interested in, such as large scale trafficking and the sale of 
marijuana to minors. The Department expressed that it was not interested in 
pursuing individual medical marijuana users. 
 
Robert A. Mikos, A Critical Appraisal of the Department of Justice’s New 
Approach to Medical Marijuana, 22 STAN. L. & POL’Y REV. 633 (2011). 
 
This Article examines the true impact of the Department of Justice’s 
(DOJ) new approach to prosecuting medical marijuana at the federal level–
the non-enforcement approach. The author argues that on its face the ap-
proach appears to be groundbreaking and ceding power to the states to 
regulate medical marijuana. However, upon closer examination the non-
enforcement approach does not really do anything. First, the author pro-
vides a brief history on state and federal medical marijuana laws and the 
federal government’s enforcement response. Next, the author looks at 
whether the DOJ’s approach actually stops criminal prosecutions. He con-
cludes that it does not for two reasons. First, because the DOJ did not create 
an enforceable right, and second, the DOJ does not have the power to moni-
tor and sanction its own employees for failing to comply with the new ap-
proach. Next, the author explores some of the civil actions that may be tak-
en by other federal agencies, private citizens, and state officials. Finally, the 
author concludes that if criminal prosecutions are truly going to be curbed 
the federal government must legalize marijuana.  
 
FAMILY LAW AND MEDICAL MARIJUANA 
David Malleis, Comment, The High Price of Parenting High: Medical Ma-
rijuana and its Effects on Child Custody Matters, 33 U. LA VERNE L. REV. 
357 (2012). 
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In this Article, the author addresses the challenges faced in permitting 
the medicinal use of marijuana in connection with family and custody is-
sues. The author notes that several states permit the use of medical marijua-
na without producing a negative impact on the medical marijuana user’s 
parental rights. Mr. Malleis summarizes the history of marijuana use rang-
ing from recreational to religious to medicinal. A brief overview of state 
law and the Controlled Substances Act is provided along with a brief dis-
cussion of Gonzales v. Raich and U.S. Attorney General Eric Holder’s 
guidelines concerning the enforcement of federal law in medical marijuana 
use instances. In addressing family law issues, the author presents three 
approaches in child custody cases. The approaches identified are: 1) “The 
Best Interest of the Child;” 2) “The Hybrid Conduct Standard,” which pro-
vides for the protection of parental rights “unless the person’s conduct cre-
ates an unreasonable danger” (the author notes that some states have legis-
lated this position while others have arrived there through judicial action); 
and 3) “The Per Se Probative Standard.” The author applies the two latter 
standards to a custody issue and discusses the possible outcomes. He also 
compares pros and cons of the standards concluding the “Hybrid Conduct 
Standard” is superior. 
 
ATTORNEY ETHICAL ISSUES AND MEDICAL MARIJUANA 
Sam Kamin & Eli Wald, Marijuana Lawyers: Outlaws or Crusaders?, 91 
OR. L. REV. 869 (2013). 
 
The authors address the issues faced by attorneys representing people 
and entities in the lawful use and provision of medical marijuana, and in 
some states legal recreational use, businesses. Much of the conflict arises 
due to the fact that at the federal level marijuana is an illegal drug. In their 
discussion of federalism the authors note that the Controlled Substances Act 
clearly does not preempt regulation of marijuana. The Department of Jus-
tice memorandum regarding enforcement is discussed and it is suggested 
that the memo does not state that enforcement will not occur in states hav-
ing adopted medical marijuana laws. The second Department of Justice 
memorandum on topic, the authors indicate, supports the view that the first 
memorandum was misinterpreted. Highlighting this misinterpretation were 
acts of the United States Attorney’s office indicting marijuana cooperatives 
and sending cease and desist letters to dispensaries. Additional issues arise, 
for example, where residents in public housing indicate that they will not 
violate criminal laws, or parolees who agree to not use controlled substanc-
es yet the states in which they reside permit medical marijuana use and in 
some instances recreational use. In covering the representation of medical 
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marijuana, client issues such as accomplice and coconspirator liability are 
discussed. The authors provide an analysis of actions where attorneys were 
found to be aiding criminal clients and they also identify the chilling effect 
such actions can have on the effective representation of criminal clients. 
With respect to the Controlled Substances Act and coconspirator or accom-
plice liability the authors indicate that there needs to be shown a mens rea 
of true intent. Also covered are ethical considerations when representing 
marijuana clients. The authors look at ABA Model Rule of Professional 
Conduct 1.2(d) in the discussion of ethical concerns. The rule, the authors 
indicate, permits an attorney to discuss medical marijuana and explain the 
potential Controlled Substances Act issues, but does not allow the drafting 
of documents related to the client’s business. The differing ethical applica-
tion stances in Arizona and Maine are also covered. An attorney’s status as 
a medical marijuana patient is looked at in the ethical considerations as 
well. Financial activities in the medical marijuana industry by lawyers, as 
well as, legal services that may be permitted to be provided by attorneys in 
the area are addressed. There are also sections on questionable and prohib-
ited legal services. 
 
Alec Rothrock, Is Assisting Medical Marijuana Dispensaries Hazardous to 
a Lawyer’s Professional Health?, 89 DENV. U.L. REV. 1047 (2012). 
 
The author examines Colorado Rule of Professional Conduct 1.2(d) in 
light of an attorney providing legal services to a medical marijuana dispen-
sary. While doing so is not a violation of Colorado law, the author notes it 
is a violation of federal law and thus creates a conflict with this rule. He 
also identifies ethics opinions from Maine and Arizona that reach opposite 
conclusions in their interpretation of Rule 1.2(d) with respect to medical 
marijuana activities. The author provides a discussion of good faith argu-
ments and provides examples outside the medical marijuana realm. Mr. 
Rothrock identifies other prohibitions from Rule 1.2(d) including counsel-
ing and assisting. He also discusses the knowledge requirement of the rule. 
He states that no Colorado lawyers have been publicly disciplined; howev-
er, under the rule it is possible and no disciplinary action thus far does not 
mean it will not happen. 
MODEL RULES OF PROFESSIONAL CONDUCT R. 1.2  
Client-Lawyer Relationship 
Scope of Representation and Allocation of Authority between Client 
and Lawyer 
 
(a) Subject to paragraphs (c) and (d), a lawyer 
shall abide by a client’s decisions concerning the 
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objectives of representation and, as required by 
Rule 1.4, shall consult with the client as to the 
means by which they are to be pursued. A lawyer 
may take such action on behalf of the client as is 
impliedly authorized to carry out the representa-
tion. A lawyer shall abide by a client's decision 
whether to settle a matter. In a criminal case, the 
lawyer shall abide by the client's decision, after 
consultation with the lawyer, as to a plea to be en-
tered, whether to waive jury trial and whether the 
client will testify. 
(b) A lawyer’s representation of a client, in-
cluding representation by appointment, does not 
constitute an endorsement of the client’s political, 
economic, social or moral views or activities. 
(c) A lawyer may limit the scope of the repre-
sentation if the limitation is reasonable under the 
circumstances and the client gives informed con-
sent. 
(d) A lawyer shall not counsel a client to en-
gage, or assist a client, in conduct that the lawyer 
knows is criminal or fraudulent, but a lawyer may 
discuss the legal consequences of any proposed 
course of conduct with a client and may counsel or 
assist a client to make a good faith effort to deter-
mine the validity, scope, meaning or application of 
the law. 
 
STATE REGULATORY ACTIONS 
Peter J. Cohen, Medical Marijuana 2010: It’s Time to Fix the Regulatory 
Vacuum, 38 J.L. MED. & ETHICS 654 (2010).  
 
The author starts by discussing the roadblock to effective research on 
the medicinal uses of marijuana imposed by its classification as a Schedule 
I drug in the Controlled Substances Act. He provides examples of the Drug 
Enforcement Agency and the National Institute of Drug Abuse not permit-
ting access to marijuana by university researchers, thus hampering their 
abilities to develop scientific information on the efficacy of medical mariju-
ana. Also discussed is the attempt in the 1990s by scientists to have the 
Drug Enforcement Agency permit such research. In 1999 the National 
Academies of Sciences’ Institute of Medicine proceedings included materi-
als indicating that marijuana had beneficial effects in dealing with chemo-
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therapy related nausea, AIDS, wasting syndrome, and some types of spas-
ticity among other conditions. Yet, these findings were not considered by 
the agencies. He indicates that the American Medical Association even 
recommended a review of the Schedule I classification of marijuana in or-
der to allow for a relaxation on access to cannabis for research purposes. 
All of the scientific and medical groups that supported a scientific evalua-
tion of the potential use of marijuana for medical purposes were not heeded 
by the federal entities able to affect the start of a change. The author pro-
vides a discussion of marijuana as a gateway drug. Mr. Cohen provides an 
overview of state attempts at regulating marijuana and focuses on Califor-
nia and Colorado. He then proposes revisions to state regulations to better 
oversee the practices related to medical marijuana. Among those is the par-
ticipation of physicians as “therapeutic gatekeepers” and state boards of 
medicine providing oversight. He concludes by reiterating the need for sci-
entific evidence to be the basis of approval of any drug for medicinal use 
and indicates such evidence exists with respect to marijuana.  
 
Robert A. Mikos, On the Limits of Supremacy: Medical Marijuana and the 
States’ Overlooked Power to Legalize Federal Crime, 62 VAND. L. REV. 
1421 (2009). 
 
The author looks at the strong position of the states to legalize activi-
ties that are banned by the federal government. While his Article focuses on 
medical marijuana he also indicates this approach is possible in other areas 
as well. A basis for this argument is that the states are permitting behavior 
(not acting with respect to it) that is banned by the federal government. Mr. 
Mikos provides an overview of state laws at the time of writing and the 
Controlled Substances Act and its constitutionality. Despite the holding in 
Gonzales v. Raich, the author does not find federal law to preempt the 
states’ legalization of medical marijuana. He provides an explanation for 
this by looking at the anti-commandeering doctrine and how it constrains 
the preemption power, and the congressional intent seen in the Controlled 
Substances Act limiting the preemptive powers of the Act. Additionally, the 
author looks at five types of state statutes with respect to legalized medical 
marijuana and discusses why these laws are likely not preempted. Mr. 
Mikos also looks at ways Congress can try to alter the state laws and 
whether these methods are appropriate or realistic. The author also provides 
a discussion of why people obey laws and how that factors into this area. 
 
Karen O’Keefe, State Medical Marijuana Implementation and Federal Pol-
icy, 16 J. HEALTH CARE L. & POL’Y 39 (2013). 
 
The author in looking at efforts to “reschedule marijuana under federal 
law,” looks at state marijuana laws and the interaction of state policies and 
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federal law in the states that have legalized marijuana. Ms. O’Keefe ad-
dresses the Schedule I Controlled Substances Act classification of marijua-
na and the unwillingness over the years of the Drug Enforcement Agency 
and the Food and Drug Administration, with support from the federal 
courts, to change the classification. She notes this resistance in the face of 
much research showing the effectiveness and safety of marijuana. She looks 
at early state legislative attempts to recognize the value of medical marijua-
na. Such laws permitted marijuana as a prescription, but doctors could not 
prescribe marijuana without potential sanctions and pharmacies could not 
fill such prescriptions under federal law. Other laws provided federal ap-
proval for small-scale programs. She covers more recent actions to legalize 
medical marijuana starting with California’s 1996 law that did not rely on 
any help or consent from the federal government. She summarizes the Cali-
fornia law as well as identifies other states that subsequently enacted medi-
cal marijuana laws. Also identified are instances where states chose not to 
enforce federal laws. Ms. O’Keefe moves on to discuss the growth of dis-
pensaries and federal impediments to these entities. She then discusses the 
start of regulated dispensaries with the 2008 New Mexico law and subse-
quent states legalizing medical marijuana and regulating its distribution to 
some extent. She concludes by identifying ways to more closely align fed-
eral and state policies. 
 
MISCELLANEOUS 
D. Mark Anderson, Benjamin Hansen, & Daniel I. Rees, Medical Marijua-
na Laws, Traffic Fatalities, and Alcohol Consumption, 56 J.L. & ECON. 333 
(2013). 
 
This Article examines the impact of legalized medical marijuana on 
road fatalities. In addition, the authors look at whether or not legalized med-
ical marijuana works as a replacement for overall alcohol consumption. 
First, the authors provide a brief history of marijuana in the United States; 
they begin with the introduction of marijuana in the early 1660s and end 
with the 1996 passage of California’s medical marijuana statute. Next, the 
authors briefly discuss driver impairments associated with alcohol or mari-
juana use. The authors concluded that while marijuana does impair drivers, 
alcohol impaired drivers tend to take more risks and underestimate their 
level of impairment. The authors also discuss the impact medical marijuana 
laws have on the marijuana market. The authors conclude that medical ma-
rijuana laws lead to a substantial decrease in the price of high-grade mariju-
ana. In addition, the demand for high-grade medical marijuana steadily in-
creases, especially among users who are under the legal age limit to con-
sume alcohol. The authors argue that this has a direct impact on the drop in 
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traffic fatalities for this age group. They assert that users in this age group 
replace alcohol with marijuana and this in turn leads to fewer fatalities be-
cause marijuana users are better drivers than their counterparts using alco-
hol. They also assert that alcohol use tends to take place at restaurants and 
bars, requiring people to drive impaired, whereas marijuana users tend to 
consume it in the home.  
 
Peter J. Cohen, Medical Marijuana: The Conflict between Scientific and 
Political Ideology, 2009 UTAH L. REV. 35 (2009). 
 
Mr. Cohen provides an overview of the FDA and its role in investigat-
ing drugs for the legal drug market. Within that overview he identifies is-
sues such as the difference in purpose and effect of medicinal and recrea-
tional use of marijuana. He also addresses arguments regarding the negative 
side effects and risks associated with marijuana use while also showing 
similar, and in some instances, greater risks existing with other authorized 
controlled substances used in medicine. Mr. Cohen spends some time 
speaking to risks such as the connection between smoking marijuana and 
pulmonary cancer, the possibility that marijuana use leads to the use of oth-
er illegal drugs–the “Gateway Hypothesis,” and uses related legal and sci-
entific materials to support his arguments. Additionally, the author provides 
a summary of the history of medical marijuana’s use prior to the passage of 
legislation making it an illegal substance and recent studies showing its 
medicinal applications and benefits. In the latter part of the Article he ad-
dresses the struggles faced due to differing scientific and political percep-
tions of the use of marijuana as a medicine, including its designation as a 
Schedule I controlled substance and how that affects its designation for use 
in medical situations, especially when smoked. Mr. Cohen also presents 
information on the use of Dronabinol and Sativex™ and compares their use 
and effects to smoked marijuana. 
 
Moira Gibbons, The Cannabis Conundrum: Medication v. Regulation, 
HEALTH LAW, Dec. 2011, at 1. 
 
The author educates the readers on the make-up of cannabis and the 
ways in which the marijuana plant is used. She also explains cannabinoids 
and among them THC. Ms. Gibbons explains how a medicine is chosen for 
treatment and the lack of studies on medical marijuana to assist in it fitting 
into that choice process. She identifies an Institute of Medicine report often 
cited by the Drug Enforcement Agency to justify keeping the ban on mari-
juana. She also identifies new drugs developed to help in areas such as 
chemotherapy-induced nausea. She indicates though that the efficacy of 
these compared to medical marijuana has not been compared. She states 
that research on plant and synthetic cannabinoids needs to continue. Some 
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of the barriers to these are the roadblocks to obtaining marijuana via gov-
ernment systems and the lack of consistency in the marijuana used. The 
author proceeds to provide an overview of the federal stance on medical 
marijuana followed by a summary of state actions in this area.  
 
John Dwight Ingram, Medical Use of Marijuana, 33 OKLA. CITY U. L. 
REV. 589 (2008). 
 
The author summarizes briefly Gonzales v. Raich. He then addresses 
actions in the states regarding medical marijuana pointing out language 
from the California law. He then moves on to discuss the Controlled Sub-
stances Act and the federal government’s “war on drugs.” A more in-depth 
discussion of Gonzales v. Raich is followed by a discussion of legalizing 
medical marijuana. He suggests several possible ways to do so. These in-
clude: 1) rescheduling marijuana; 2) amending the Controlled Substances 
Act; or 3) bringing a new case before the U.S. Supreme Court that changes 
the stance taken in Gonzales v. Raich.  
 
Sam Kamin, The Limits of Marijuana Legalization in the States, 99 IOWA 
L. REV. 39 (2014). 
 
This Article explores the pitfalls of medical marijuana with regards to 
running a business. The author traces this back to the core federalism is-
sue—the states are trying legalize something that is not in their power to 
legalize. The Article not only briefly maps out the federalism issue and 
explores how the Department of Justice Memorandums muddy the issue, 
but it also explores several legal and business areas that are particularly 
affected by this issue. These areas are: employment law, probation/parole 
rules, contracting, and banking. The author argues that until the federalism 
issue is resolved in a meaningful way, medical marijuana will never be able 
to become a legitimate tax generating part of the economy. 
 
Linda Simoni-Wastila & Francis B. Palumbo, Medical Marijuana Legisla-
tions: What We Know - and Don’t, 16 J. HEALTH CARE L. & POL’Y 59 
(2013). 
 
In this Article the authors review medical marijuana policies and laws 
and provide suggestions for the evaluation of medical marijuana laws and 
their implementation. Also covered are the known and unknown health 
outcomes as well as the identification of knowledge gaps in areas such as 
social outcomes, dispensary models, and data collection. The data collec-
tion limitations are highlighted by the authors who indicate their belief that 
the best course would be a database analyzing medical marijuana on a 
number of levels including medical, social, and criminal, among others. The 
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authors recommend further study of best models for dispensaries and pro-
vide potential models. The authors discuss Risk Evaluation and Mitigation 
Strategies of the Food and Drug Administration and indicate that medical 
marijuana would be a good candidate for this. Also provided is a discussion 
of participation in drug monitoring programs. 
 
William Vertes & Sarah Barbantini, Caught in the Crossfire: The Dilemma 
of Marijuana “Medicalization” for Healthcare Providers, 58 WAYNE L. 
REV. 103 (2012-2013). 
 
The authors provide a history of marijuana use dating back to 1500 
B.C., when the Chinese used it for medicinal purposes. They also point to 
its inclusion in the United States Pharmacopeia in the 1950s. The change in 
perception of marijuana and its move to a controlled substance is chroni-
cled. The classification of substances as “drugs” and the categories into 
which drugs fall under the Comprehensive Drug Abuse Control Act is re-
viewed along with whether medical marijuana falls within the second cate-
gory. The Controlled Substances Act is discussed with a summary of the 
process for modification of a drug placed within the Controlled Substances 
Act’s five schedules. Additionally, the authors discuss what a medicine is 
and whether separate from being a drug is marijuana a medicine. A discus-
sion is also presented on the benefits and pitfalls to both sides if marijuana 
were reclassified or remained on Schedule I of the Controlled Substances 
Act. For example, the current models do not involve licensed pharmacists, 
but rather medical marijuana is self-grown, obtained from a caregiver, or 
through a dispensary, whereas reclassification as a prescription would in-
volve working through a pharmacist. A significant portion of the work fo-
cuses on the Michigan Medical Marijuana Act. In discussing the Michigan 
Act the authors note the requirement of a physician’s evaluation for a regis-
try card and the fact that a physician cannot prescribe marijuana because of 
its lack of recognition for medical use. Also noted is the Act’s requirement 
of a bona-fide physician-patient relationship without defining the term, 
however they note subsequent legislation was introduced to help clarify this 
area. Additionally, the requirements of the Board of Health Professionals 
with respect to physicians certifying patients for medical marijuana use 
provide clarification. 
 
Michael Vitiello, Why the Initiative Process is the Wrong Way to Go: Les-
sons We Should Have Learned from Proposition 215, 43 MCGEORGE L. 
REV. 63 (2012). 
 
The author provides a history of California’s Proposition 215, which 
legalized medical marijuana use in the state, from before its enactment 
when the federal government had the Compassionate Use Program in effect 
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to its passage and subsequent legislative and judicial actions. The author 
covers what he terms “drafting problems” with the initiative. Among those 
he includes the lack of information on where to obtain marijuana, the am-
biguous definition of terms such as “primary caregiver,” and the initiative’s 
lack of defenses for actions such as transporting marijuana. He indicates 
how, over the years, courts and the legislature have had to address issues 
not originally addressed by the proposition such as defining a physician’s 
recommendation or approval and defining a caregiver. The author summa-
rizes the 2004 Medical Marijuana Program Act and how it resolved some of 
the initial issues presented by Proposition 215. He also covers 2008 guide-
lines from the state Attorney General that provided guidance the author 
indicates was needed twelve years earlier, including regulation guidelines 
for dispensaries. In addressing his main contention that the initiative pro-
cess is not the way to bring about laws, the author identifies the following 
concerns: 1) the proposition resulted from a manipulation of the initiative 
process rather than through true debate; 2) the initiative process limits the 
ability of the legislature to reform the law if the proposed legislation is not 
consistent with the initiative; and 3) in the case of Proposition 215 the 
“chaos” of the previous fifteen years had led to human and economic costs. 
In discussing whether it is worthwhile to continue a discussion of the legal-
ization of medical marijuana he identifies the strong support for doing so, 
which is unlike support for any other drug. Another factor he looks at is the 
positive economic effect legalization might have in many jurisdictions, 
while also identifying additional possible costs that will come about from 
legalization. Also identified by the author as tipping the scale toward legali-
zation is the large number of persons incarcerated in the United States for 
drug related offenses. He then provides a look at the possible means by 
which to legalize marijuana. 
 
NEWSPAPER COVERAGE 
The following section provides a brief list of newspaper articles from 
the last year addressing various aspects of the medical marijuana debate. 
 
RECENT NEW YORK TIMES ARTICLES 




Los Angeles County voted to ban marijuana delivery services. A judge 
in the Los Angeles County Superior Court issued a preliminary injunc-
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tion against the developers of an app that provided delivery of mariju-
ana. 
 




Looks at the challenges of states with legalized recreational use and 
the issues with taxes and “black market sales.” 
 




Ian Lovett, Berkley Pushes a Boundary on Medical Marijuana, N.Y. TIMES 
(Sept. 2, 2014), http://www.nytimes.com/2014/09/03/us/03berkeley.html. 
 
The article discusses the effort in Berkley to provide medical marijua-
na to low income residents. 
 
STATES DIFFERENT ACTIONS ON MEDICAL MARIJUANA 
Florida Medical Marijuana Backers Seek Law, Ballot Drive in 2016, N.Y. 




Illinois Legalizes Medical Marijuana for Children with Seizures, N.Y. 




North Carolina Joins States Allowing Limited Medical Marijuana, N.Y. 




INTERNATIONAL ACTIONS ON MEDICAL MARIJUANA 
Brazil to Study Legalization of Medical Marijuana, N.Y. TIMES (Dec. 19, 
2014), http://www.nytimes.com/aponline/2014/12/19/world/americas/ap-lt-
brazil-medical-marijuana.html.  
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RECENT HUFFINGTON POST ARTICLES  
Rachelle Friedman, Bill to Legalize Medical Marijuana in Pennsylvania 





Hunter Stewart, Minnesota Wants to Legalize Medical Marijuana, But Po-




Gary Stein, God Becomes a Passive Lobbyist for Medical Marijuana, 
HUFFINGTON POST (Feb. 24, 2014), http://www.huffingtonpost.com/gary-
stein/god-becomes-a-passive-lobbyist_b_4824659.html. 
 
The 420 Times, Washington Lawmakers Vote to Revise Medical Marijuana 




Matt Ferner, Epilepsy Group Announces Support for Medical Marijuana, 




Christopher Mathias, New York Moves Closer To Legalizing Medical Mari-
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Illinois’ Proposed Medical Marijuana Rules Could Squeeze out Small 




Matt Ferner, Number of Children Seeking Medical Marijuana Soars in Col-




Hunter Stewart, Kentucky Considers Legalizing Medical Marijuana, 




Russ Belville, NRA Quiet on Disarming Legal Medical Marijuana Patients, 
HUFFINGTON POST (Feb. 7, 2014), http://www.huffingtonpost.com/russ-
belville/nra-medical-marijuana_b_4740222.html. 
RECENT CHICAGO TRIBUNE ARTICLES 
Chuck Fieldman, Medical Marijuana Has Several Uses, Says Oak Brook 




Mike Danahey et al., State Passes on Medical Marijuana Dispensary in 




Robert McCoppin, Two Chicago Medical Marijuana Store Licenses Ap-
proved, CHI. TRIB. (Feb. 7, 2015), http://www.chicagotribune.com/news/ct-
medical-marijuana-dispensary-license-met-20150206-story.html. 
 
Marwa Eltagouri, State Rejects Proposal for Batavia Medicinal Pot Culti-





Rick Kambic, Mundelein Lands All 3 Medical Marijuana Dispensaries in 
Lake County, CHI. TRIB. (Feb. 5, 2015), 




Robert McCoppin, State Approves 1,000 for Medical Pot; Drug Access 




Susan Frick Carlman, Medical Pot OK Includes Naperville Site, CHI. TRIB. 
(Feb. 3, 2015), http://www.chicagotribune.com/suburbs/naperville-
sun/news/ct-nvs-medical-marijuana-rauner-st-0204-20150203-story.html. 
 
Ellen Jean Hirst et al., For Illinois Businesses that Won Medical Pot Per-




Alex V. Hernandez, Medical Marijuana Shop Gets state’s OK to Open in 
Oak Park, CHI. TRIB. (Feb. 3, 2015), 
http://www.chicagotribune.com/suburbs/oak-park/news/ct-oak-marijuana-
tl-0212-20150203-story.html. 
 
